United Therapeutics Corporation (UTHR)

500 USD

0.3

0.06%

Last update Dec 16, 3:59 PM EST

Market closed

Day range

500

491.76001

502.76999

Previous close

500.29999

Open

497.17001

Access this stock data via API

United Therapeutics Corporation

500.00

0.30

0.06%

Earnings estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of analysts	11	4	13	13
Average estimate	6.88	7.02	27.10	28.49
Low estimate	3.38	6.06	25.17	24.47
High estimate	7.94	7.95	28.98	32.44
Last year EPS	6.19	6.63	24.64	27.10

Access /earnings_estimate data via our API — starting from the Ultra plan.

Revenue estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	11	5	13	13
Avg. estimate	818.74M	817.94M	3.21B	3.39B
Low estimate	779.40M	792.10M	3.15B	3.09B
High estimate	856.40M	849M	3.25B	3.55B
Last year sales	735.90M	794.40M	2.88B	3.21B
Sales growth	0.11	0.03	0.11	0.06

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS trend	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Current estimate	6.88	7.02	27.10	28.49
7 days ago	6.87	6.99	27.11	28.56
30 days ago	6.51	7.28	26.65	28.04
60 days ago	6.43	7.20	26.48	27.60
90 days ago	6.42	7.02	26.59	27.78

Access /eps_trend data via our API — starting from the Ultra plan.

EPS revisions	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	0	1	0	1
Up last 30 days	8	2	8	8
Down last 7 days	0	0	0	0
Down last 30 days	2	1	3	3

Access /eps_revisions data via our API — starting from the Ultra plan.

Access /growth_estimates data via our API — starting from the Ultra plan.

Buy

35.7%

Neutral

57.1%

Buy

7.1%

Strong buy

Access /recommendations data via our API — starting from the Ultra plan.

Access /analyst_ratings/light data via our API — starting from the Ultra plan.